Citation tools
"Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension." European Respiratory Journal
38.Suppl 55
(2011):
p2292.
Web. 22 Mar. 2023.